Concentrix Corp has a consensus price target of $79.75, established from looking at the 15 latest analyst ratings. The last 3 analyst ratings were released from Scotiabank, B of A Securities, and Barrington Research on April 29, 2024, March 27, 2024, and March 27, 2024. With an average price target of $56.33 between Scotiabank, B of A Securities, and Barrington Research, there's an implied -12.90% downside for Concentrix Corp from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/29/2024 | Buy Now | 31.42% | Scotiabank | Divya Goyal | $120 → $85 | Maintains | Sector Outperform | Get Alert |
03/27/2024 | Buy Now | — | B of A Securities | Ruplu Bhattacharya | — | Downgrade | Neutral → Underperform | Get Alert |
03/27/2024 | Buy Now | 29.87% | Barrington Research | Vincent Colicchio | $121 → $84 | Maintains | Outperform | Get Alert |
03/20/2024 | Buy Now | 87.07% | Barrington Research | Vincent Colicchio | $121 → $121 | Maintains | Outperform | Get Alert |
01/25/2024 | Buy Now | 87.07% | Barrington Research | Vincent Colicchio | $98 → $121 | Maintains | Outperform | Get Alert |
08/24/2023 | Buy Now | 85.53% | Scotiabank | Divya Goyal | → $120 | Initiates | → Sector Outperform | Get Alert |
06/29/2023 | Buy Now | 46.88% | B of A Securities | Ruplu Bhattacharya | — | Downgrade | Buy → Neutral | Get Alert |
06/29/2023 | Buy Now | 51.52% | Barrington Research | Vincent Colicchio | $165 → $98 | Maintains | Outperform | Get Alert |
06/26/2023 | Buy Now | 155.1% | Barrington Research | Vincent Colicchio | → $165 | Reiterates | Outperform → Outperform | Get Alert |
04/12/2023 | Buy Now | 131.91% | Canaccord Genuity | Joseph Vafi | → $150 | Initiates | → Buy | Get Alert |
03/30/2023 | Buy Now | 155.1% | Barrington Research | Vincent Colicchio | → $165 | Reiterates | → Outperform | Get Alert |
03/27/2023 | Buy Now | 155.1% | Barrington Research | Vincent Colicchio | → $165 | Reiterates | → Outperform | Get Alert |
09/30/2022 | Buy Now | 169.02% | Barrington Research | Vincent Colicchio | $183 → $174 | Maintains | Outperform | Get Alert |
07/05/2022 | Buy Now | 182.93% | Barrington Research | Vincent Colicchio | $202 → $183 | Maintains | Outperform | Get Alert |
06/15/2021 | Buy Now | 181.39% | Barrington Research | Vincent Colicchio | — | Initiates | → Outperform | Get Alert |
The latest price target for Concentrix (NASDAQ: CNXC) was reported by Scotiabank on April 29, 2024. The analyst firm set a price target for $85.00 expecting CNXC to rise to within 12 months (a possible 31.42% upside). 9 analyst firms have reported ratings in the last year.
The latest analyst rating for Concentrix (NASDAQ: CNXC) was provided by Scotiabank, and Concentrix maintained their sector outperform rating.
There is no last upgrade for Concentrix.
The last downgrade for Concentrix Corp happened on March 27, 2024 when B of A Securities changed their price target from N/A to N/A for Concentrix Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Concentrix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Concentrix was filed on April 29, 2024 so you should expect the next rating to be made available sometime around April 29, 2025.
While ratings are subjective and will change, the latest Concentrix (CNXC) rating was a maintained with a price target of $120.00 to $85.00. The current price Concentrix (CNXC) is trading at is $64.68, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.